MFNS + Oxymetazoline in Seasonal Allergic Rhinitis

Phase 2, randomised, double-blind trial of mometasone furoate nasal spray and Mucinex Full Force Nasal Spray in seasonal allergic rhinitis (SAR) (5 arms), sponsored by Organon & Co. Primary endpoints: Change From Baseline in AM/PM Instantaneous Total Nasal Symptom Score at 15 days and Standardized Area Under the Curve From 0 to 4 Hours of the Change From Baseline to Hour 4 on Day 1 in Nasal Congestion Score. Started Jul 2007; status: completed.